- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07259629
Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients (FIGS)
November 20, 2025 updated by: Guy's and St Thomas' NHS Foundation Trust
Fasting is a requirement to safely anesthetise patients referred for elective procedure, using the traditional 6/4/2 rule (6h for solid food or formula milk, 4h for breast milk and 2h for clear fluids), applied to all patients regardless of their age or weight.
Reducing the aspiration risk however puts young children at higher risk of hypoglycemia due to the immaturity of their endocrine system and absence of metabolic reserves.
The Association of Paediatric Anaesthetists of Great Britain and Ireland recommends that during day case surgery the majority of children may be given fluids without dextrose, provided blood glucose is monitored.
Recent statements recommend continuing fluids until 1h before the procedure or even to give fluids when anesthetists sent for the patients.
Hypoglycemia is rare in children above 2 years of age.
Although the definition of hypoglycemia can differ, a threshold of 3.6mmol/l is often used given the potential neurological harm existing below this value.
There is no consensus on the definition of hypoglycemia in children being fasted prior to general anesthesia, nor when nor how to treat it.
Measurements are done for complex surgeries or patients deemed at risk according to the anesthetists.
An audit was run in 2017 at the " Evelina London Children's Hospital ", Guy's and St Thomas' National Health Service Foundation Trust, identifying 8% of children below 2 years of age as hypoglycemic.
Recent review of our Incident Reporting Systems identified 3 cases, in otherwise fit and healthy children, referred for colonoscopy with initial hypoglycemia followed by rebound hypoglycemia after management.
There is an urgent need to establish a clear definition of hypoglycemia and investigate risk factors in paediatric patients referred for elective procedures under general anesthesia.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
6580
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Benjamin Blaise, MD PhD
- Phone Number: +447478741874
- Email: gstt.figsstudy@nhs.net
Study Locations
-
-
-
London, United Kingdom, EC1V 2PD
- Completed
- Moorfields Eye Hospital
-
London, United Kingdom, SE17EH
- Recruiting
- Evelina London Children's Hospital
-
Contact:
- Benjamin Blaise Blaise, MD PhD
- Phone Number: +447478741874
- Email: gstt.figsstudy@nhs.net
-
-
Devon
-
Exeter, Devon, United Kingdom, EX2 5DW
- Recruiting
- Royal Devon University Healthcare NHS Foundation Trust
-
Contact:
- Philippa Dix, FRCA
- Phone Number: +441392411611
- Email: philippa.dix@nhs.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Pediatric patients fasting for a procedure under general anesthesia
Description
Inclusion Criteria:
- All American Society of Anesthesiology score (ASA) 1 - 3 children aged 1 month to 18 years presenting for an elective procedure involving general anaesthesia during the defined study period
- All elective cases, day cases will be included (patient's admitted the night before for bowel preparation prior to elective colonoscopy should also be included)
- Planned expedited cases in ASA 1 / 2 children should be included, for example nail bed repairs, lacerations, foreign body (in ear / eye / nose), simple fractures for manipulation under anesthesia / k-wires
- MRI, radiology and dental cases will be included provided the patient receives a general anaesthetic
Exclusion Criteria:
- Children aged less than 1 month
- Procedures performed under oral sedation or local anaesthesia only
- ASA status 4 and 5
- Children with any endocrine or metabolic condition or who have a fasting plan prior to general anaesthesia for glucose control:
- Type 1 or 2 diabetes mellitus, medium chain acetyl Co-enzyme A, maple syrup urine disease, glycogen storage disease, galactosaemia, urea cycle defects, familial hypercholesterolaemia, congenital disorders of glycosylation, lysosomal storage disorders, organic acidaemias, mitochondrial disorders, adrenal gland disorders, adrenoleukodystrophy, growth disorders, lipid disorders, multiple endocrine neoplasia type 1 and 2, pituitary disorders.
- Emergency and oncology procedures as these children will have different risk factors for hypoglycaemia
- Anaesthetic involvement in critically ill children e.g. airway management in emergency department, pediatric intensive care unit
- Children on glucose containing intravenous solutions or total parenteral nutrition pre-operatively
- Children on systemic steroid treatment (oral / intravenous). Children on inhalers / topical steroids should be included
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical definition if hypoglycemia
Time Frame: Immediately/within five minutes after anesthesia induction
|
Blood glucose values triggering a response from the anaesthetists with initiation of a hypoglycaemia treatment following a blood glucose measurement during anaesthetic induction
|
Immediately/within five minutes after anesthesia induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
4mmol/l as a suitable threshold of hypoglycemia
Time Frame: Immediately/within five minutes after anesthesia induction
|
Number of patient with a blood glucose measurement below 4mmol/l and being treated as hypoglycaemic by an anaesthetist following a blood glucose measurement during anaesthetic induction
|
Immediately/within five minutes after anesthesia induction
|
|
Distribution of glycemic measurements in fasting children
Time Frame: Immediately/within five minutes after anesthesia induction
|
Blood glucose values in children undergoing elective procedure under general anaesthesia.
|
Immediately/within five minutes after anesthesia induction
|
|
Age as a risk factor of hypoglycaemia
Time Frame: Immediately/within five minutes after anesthesia induction
|
Number of children below 24 months of age reported as hypoglycaemic by an anaesthetist following a blood glucose measurement during anaesthetic induction
|
Immediately/within five minutes after anesthesia induction
|
|
Weight as a risk factor of hypoglycaemia
Time Frame: Immediately/within five minutes after anesthesia induction
|
Number of children weighing less than 10kg and considered as hypoglycaemic by an anaesthetist following a blood glucose measurement during anaesthetic induction
|
Immediately/within five minutes after anesthesia induction
|
|
Distribution of blood ketone measurements in children fasting
Time Frame: Immediately/within five minutes after anesthesia induction
|
Blood ketone values in children undergoing elective procedure under general anaesthesia.
|
Immediately/within five minutes after anesthesia induction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2025
Primary Completion (Estimated)
March 30, 2026
Study Completion (Estimated)
January 12, 2027
Study Registration Dates
First Submitted
July 16, 2024
First Submitted That Met QC Criteria
November 20, 2025
First Posted (Actual)
December 2, 2025
Study Record Updates
Last Update Posted (Actual)
December 2, 2025
Last Update Submitted That Met QC Criteria
November 20, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 329701
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia
-
Samsun UniversityCompletedAnesthesia | Regional Anesthesia | Anesthesia ManagementTurkey
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
Aligarh Muslim UniversityCompletedAnesthesia | Anesthesia Intubation Complication | Anesthesia; Adverse EffectIndia
-
Universitas Sebelas MaretIndonesia Endowment Fund for EducationNot yet recruitingAnesthesia | Anesthesia; Reaction
-
University Health Network, TorontoActive, not recruiting
-
University of PecsCompleted
-
Hormozgan University of Medical SciencesUnknownAnesthesia | Anesthesia; FunctionalIran, Islamic Republic of
-
Ankara City Hospital BilkentCompletedAnesthesia | Sedation | Anesthesia, Intravenous | Sedation Complication | Recovery From Anesthesia | Monitoring of Depth of AnesthesiaTurkey (Türkiye)
-
Children's Hospital Los AngelesNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingAnesthesia | Anesthesia; ReactionUnited States